Lucy Dagher

Caracas, A, Bolivarian Republic of Venezuela

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Overcoming barriers to HCV screening in Latin America: from evidence to action.

Overcoming barriers to HCV screening in Latin America: from evidence to action.

Journal: Annals of hepatology

Published: October 27, 2025

Overcoming barriers to HCV screening in Latin America: From evidence to action.

Overcoming barriers to HCV screening in Latin America: From evidence to action.

Journal: Annals of hepatology

Published: October 27, 2025

ALEH position statement on the management of hepatitis B virus infection 2025.

ALEH position statement on the management of hepatitis B virus infection 2025.

Journal: Annals of hepatology

Published: September 16, 2025

Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver.

Drug-induced liver injury: A management position paper from the Latin American Association for Study of the liver.

Journal: Annals of hepatology

Published: November 27, 2020

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease.

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease.

Journal: The lancet. Gastroenterology & hepatology

Published: September 24, 2020

Sorafenib treatment by Child-Pugh score in Latin American patients with hepatocellular carcinoma.

Sorafenib treatment by Child-Pugh score in Latin American patients with hepatocellular carcinoma.

Journal: Future oncology (London, England)

Published: August 14, 2020

Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease.

Genetic diversity of hepatitis B virus and mutations associated to hepatocellular carcinoma in patients from Venezuela, with different stages of liver disease.

Journal: Investigacion clinica

Published: July 08, 2016

TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.

TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON.

Journal: Radiology

Published: January 09, 2016

Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.

Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: July 10, 2015

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.

Observational registry of sorafenib use in clinical practice across Child-Pugh subgroups: The GIDEON study.

Journal: Journal of hepatology

Published: April 16, 2015

Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.

Latin American Association for the Study of the Liver recommendations on treatment of hepatitis C.

Journal: Annals of hepatology

Published: September 05, 2014

Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma.

Latin American Association for the Study of the Liver (LAASL) clinical practice guidelines: management of hepatocellular carcinoma.

Journal: Annals of hepatology

Published: July 08, 2014

Showing 1-12 of 14

Last Updated: 09/26/2026